tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Schulte, 326 are a BUY (82.95%), 67 are a HOLD (17.05%).
Analyst Catherine Schulte, currently employed at BAIRD, carries an average stock price target met ratio of 73.59% that have a potential upside of 22.55% achieved within 287 days.
Catherine Schulte’s has documented 780 price targets and ratings displayed on 14 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on TWST, Twist Bioscience Corp at 03-Aug-2026.
Analyst best performing recommendations are on TWST (TWIST BIOSCIENCE CORP).
The best stock recommendation documented was for TWST (TWIST BIOSCIENCE CORP) at 8/4/2026. The price target of $115 was fulfilled within 1 day with a profit of $15.55 (15.64%) receiving and performance score of 156.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Nov-2025
$185
$12.21 (7.07%)
$155
1 months 4 days ago
(27-Aug-2026)
27/30 (90%)
$27.31 (17.32%)
442
Buy Since 02-Jun-2026
$180
$7.21 (4.17%)
$155
1 months 4 days ago
(27-Aug-2026)
5/6 (83.33%)
$22.31 (14.15%)
70
Buy Since 09-Oct-2025
$190
$17.21 (9.96%)
$180
1 months 4 days ago
(27-Aug-2026)
1/3 (33.33%)
$32.31 (20.49%)
348
Buy Since 06-Apr-2026
$172
$-0.79 (-0.46%)
$148
1 months 4 days ago
(27-Aug-2026)
19/19 (100%)
$14.31 (9.07%)
120
Buy Since 22-Aug-2024
$190
$17.21 (9.96%)
$185
1 months 4 days ago
(27-Aug-2026)
21/26 (80.77%)
$32.31 (20.49%)
185
Which stock is Catherine Schulte most bullish on?
Which stock is Catherine Schulte most reserved on?
What Year was the first public recommendation made by Catherine Schulte?
